CN Stock MarketDetailed Quotes

688331 RemeGen Co., Ltd.

Watchlist

30.70
-2.66-7.97%

Market Closed Oct 11 15:00 CST

16.71BMarket Cap-10520P/E (TTM)

RemeGen Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RemeGen Co., Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.331B	--
--	2024/FY	-- / 1.698B	--
--	2023/FY	1.083B / 1.129B	--
Mar 30, 2023	2022/FY	772.109M / 870.124M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.331B--

--2024/FY-- / 1.698B--

--2023/FY1.083B / 1.129B--

Mar 30, 20232022/FY772.109M / 870.124M--

--------

Unlock Free Earnings Estimates

Open Account

RemeGen Co., Ltd. Earnings Reports

Remegen Biopharmaceutical (Yantai) Co., Ltd. 2024 Semi-annual Report

Aug 16 12:00 ET

Summary of Remegen (Yantai) Co., Ltd.'s 2024 Interim Report

Aug 16 12:00 ET

Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 First Quarter Report

Apr 26 12:00 ET

Rongchang Biotech 2023 Annual Report

Mar 27 12:00 ET

Analyst Rating

Updated: Oct 12, 2024

Strong Buy

Strong Buy
90.00%
Buy
10.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall